Skip to content
MamaGLP — home

Mama-Match

Rank #243 for first-timers · Grade C

Lyfe Rx review

Compounded semaglutide at $225/mo and tirzepatide at $299/mo, shipped everywhere except Alabama — but the FDA issued Lyfe Rx its own FDA warning letter on 09/09/2025 for false or misleading claims about these exact products, confirmed directly on FDA.gov and never mentioned by the site itself.

$225/mo
Flat price · any dose
Consult Medication Shipping
Meet Lyfe Rx
  • HSA / FSA eligible
  • Independently scored
  • No insurance needed
Compare other providers ↓
Written by Camila Rael, editora mom, not a clinician treating youReviewed

Our medical guides link to published research and official medication information. Provider reviews compare published costs and terms. These source checks do not replace clinical review or advice from your healthcare professional.

Other providers to compare with Lyfe Rx

Providers to compare, with referral partners listed first. Placement and score are separate; some links earn MamaGLP a commission.

  • Compounded semaglutide and tirzepatide with advertised flat prices; clarify the offer and renewal rules before paying.

    Meet CoreAge Rx
  • $149 or $199 every four weeks; separate annual prepayment and a September 2025 FDA warning letter.

    Meet Sprout Health
  • Brand only: Wegovy pill from about $149/mo, Zepbound about $349–$499/mo, with a real video visit — pricier and with more moving parts than a flat compounded plan, but transparent.

    Meet Sesame

Lyfe Rx at a glance

Semaglutide
$225/mo
Tirzepatide
$299/mo
Coverage
All states except Alabama
Brand-name
Compounded only

How we scored Lyfe Rx

Each factor is judged from Lyfe Rx's actual pricing, disclosures and support, then combined into the Mama-Match Score of 47/100 using the same weighted six-factor framework we apply to every provider — never influenced by whether a provider pays us.

Getting started50/100 · Weak

Considers the intake steps, payment timing and information available before enrollment.

Price transparency55/100 · Weak

Considers the full treatment cost, introductory offers and billing commitments.

Clinical support20/100 · Weak

Considers the described clinical team, appointment access and ways to contact a prescriber.

State availability78/100 · Fair

Considers published state coverage and treatment-specific eligibility limits.

Ongoing support35/100 · Weak

Considers follow-up appointments, refill reviews and access to ongoing clinical support.

Cancellation terms38/100 · Weak

Considers cancellation deadlines, refund limits and prepaid commitments.

How we verified this review

Last reviewed
August 2026
Confidence
High
Primary sources

Company website and regulatory records

$225 and $299, with no promotion involved, in every state but Alabama. The FDA wrote to thelyferx.com on 9 September 2025 over false or misleading claims about its compounded semaglutide and tirzepatide — and the site mentions it nowhere.

Another option to compare

Visit Gala Health

We may earn a commission if you sign up through this link.

What to expect when you sign up

We walked Lyfe Rx's public signup (August 2026) — a first-hand look at the process. We did not create accounts, enter medical information, or complete checkout, so this is what any visitor sees, not a patient's outcome.

  1. 1The pricing and FAQ pages load complete and readable, with nothing hidden behind a step
  2. 2Regular pricing is stated directly on the page, before account creation
  3. 3The site itself makes no mention of its own FDA warning letter — that fact came from FDA.gov, not the provider's own copy

What we noticed

  • The FDA issued Lyfe Rx an FDA warning letter dated 09/09/2025, addressed to thelyferx.com by name, for misbranding under FDCA sections 502(a) and 502(bb) — the letter found the site's claims about compounded semaglutide and tirzepatide false or misleading
  • The site displays a LegitScript Certified badge and states it ships everywhere except Alabama
  • No account was created and no checkout completed — pricing facts come from the public site; the regulatory finding comes from FDA.gov

Pricing

Prices re-verified

  • Compounded semaglutide

    $225

    Plan

    Compounded semaglutide

  • Compounded tirzepatide

    $299

    Plan

    Compounded tirzepatide

HSA/FSA is usually accepted for GLP-1 telehealth — check your plan. Prices reflect what Lyfe Rx disclosed publicly at our last review and change often; confirm the current number on Lyfe Rx's site.

What we like

  • Broad coverage — ships everywhere except Alabama
  • Both molecules available on one site
  • LegitScript Certified badge displayed
  • Pricing stated plainly, no bait-and-switch first month found

The caveats

  • The FDA issued Lyfe Rx an FDA warning letter dated 09/09/2025 for false or misleading claims about its compounded semaglutide/tirzepatide products — confirmed on FDA.gov
  • The site makes no mention of the warning letter anywhere in its own copy
  • Not available in Alabama
  • Nothing on pregnancy, breastfeeding, postpartum recovery, or PCOS

Lyfe Rx for moms: our verdict

Compounded semaglutide at $225/mo and tirzepatide at $299/mo, shipped everywhere except Alabama — but the FDA issued Lyfe Rx its own FDA warning letter on 09/09/2025 for false or misleading claims about these exact products, confirmed directly on FDA.gov and never mentioned by the site itself. It runs about $225/mo, flat across every dose — pricier than the category, so the extras have to earn it.

We looked at Lyfe Rx the way moms actually have to: not just the monthly cost, but the right timing around pregnancy and nursing and honest, clear pricing from the start — the parts a generic weight-loss review skips.

What Lyfe Rx actually costs

  • Compounded semaglutide — Compounded semaglutide: $225/mo
  • Compounded tirzepatide — Compounded tirzepatide: $299/mo

For context, the typical ongoing price on our list is around $179/mo, so Lyfe Rx sits at the pricier end.

Lyfe Rx prices flat across doses, so it doesn't climb as your dose does — which matters, because most women spend months titrating up.

That price covers the consult, the medication and shipping.

The medications Lyfe Rx prescribes

Lyfe Rx lists semaglutide and tirzepatide. Offering both gives a prescribing clinician options, but PCOS or a history of gestational diabetes alone does not establish which medication is right for you. Compounded GLP-1s are not FDA-approved finished products. Confirm the exact formulation and dispensing pharmacy; an approved brand’s trial results do not establish the quality or equivalence of a compounded product.

Where it operates. Lyfe Rx lists its coverage as: All states except Alabama.

Where Lyfe Rx fits — and where it doesn't — for moms

A good fit if…

  • you want to discuss both semaglutide and tirzepatide with your prescribing clinician.

Look elsewhere if…

  • you specifically want an FDA-approved brand-name pen with its own pregnancy and breastfeeding label.
  • a clean regulatory record is non-negotiable for you — look at the FDA warning letter flagged in the cons above.
  • you need to discuss the right timing around pregnancy and nursing with your treating clinician before choosing. If comparing prices with CoreAge Rx, request the offer and terms separately from that clinical decision.

Trust, safety and oversight

Before choosing Lyfe Rx, confirm the dispensing pharmacy and the clinician responsible for your prescription. Public information alone does not establish the quality of care you will receive. It has an FDA warning letter, flagged in the cons — read it before you start. As with any compounded GLP-1, the most useful thing moms can do is confirm which licensed pharmacy fills the prescription and what's in the formula — we explain how we score oversight in our scoring methodology.

Pregnancy and breastfeeding need separate discussions with your clinician. GLP-1 weight-loss treatment is not recommended during pregnancy. During breastfeeding, the exact drug and formulation matter: Wegovy tablets are not recommended because of the SNAC absorption ingredient. Injectable semaglutide and tirzepatide labels call for weighing benefits, risks and the limits of infant-safety data; they do not establish that treatment is safe for every nursing parent. Compounded products do not inherit FDA approval from the branded drug. Discuss your own medication and timing before starting or changing treatment.

The bottom line

Lyfe Rx is a provider we list only with the full story attached — weigh it on the right timing around pregnancy and nursing and honest, clear pricing from the start against the alternatives below. For moms comparing another compounded offer, CoreAge Rx describes prices and terms to confirm for the selected dose and plan.

The bottom line

Best for: No mom, until the warning letter is resolved — read the FDA's own finding about its marketing claims before its price does the deciding.

Keep comparing Lyfe Rx

Lyfe Rx, answered

Does Lyfe Rx have an FDA warning letter?
Yes — dated 09/09/2025, addressed to thelyferx.com by name, over misleading claims about its compounded semaglutide and tirzepatide. Confirmed directly on FDA.gov; the site itself doesn't mention it.

Prices, states and verification reflect what Lyfe Rx disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the published methodology. This is background information, not medical advice. Pregnancy and breastfeeding guidance depends on the drug and formulation. Read the current Wegovy label and Zepbound label. See our medical disclaimer and how we're funded.

← Back to all providers